{"entity":{"type":"insider","cik":"0001474684","url":"/insider/0001474684","json_url":"/insider/0001474684.json","name":"Slilaty Steve N.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2012-09-07","last":"2024-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Slilaty Steve N.","source":"filing","n_filings":5,"first_seen":"2012-09-07","last_seen":"2024-03-05"}],"transactions":[{"id":2746572,"accession":"0001683168-24-001322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-24-001322","line_url":"/filing/0001683168-24-001322#line-1","is_derivative":false,"issuer_cik":"0001402328","issuer_name":"Sunshine Biopharma, Inc","issuer_ticker":"SBFM","issuer_name_source":null,"issuer_url":"/issuer/0001402328","owner_cik":"0001474684","owner_name":"Slilaty Steve N.","owner_display_name":"Slilaty Steve N.","owner_url":"/insider/0001474684","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Series B Preferred Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":130000.0,"shares_owned_after_display":"130,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":2260666,"accession":"0001683168-24-000879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-24-000879","line_url":"/filing/0001683168-24-000879#line-1","is_derivative":false,"issuer_cik":"0001402328","issuer_name":"Sunshine Biopharma, Inc","issuer_ticker":"SBFM","issuer_name_source":null,"issuer_url":"/issuer/0001402328","owner_cik":"0001474684","owner_name":"Slilaty Steve N.","owner_display_name":"Slilaty Steve N.","owner_url":"/insider/0001474684","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Series B Preferred Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-12","scope":"insider"},{"id":2742272,"accession":"0001128732-16-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001128732-16-000018","line_url":"/filing/0001128732-16-000018#line-1","is_derivative":false,"issuer_cik":"0001402328","issuer_name":"Sunshine Biopharma, Inc","issuer_ticker":"SBFM","issuer_name_source":null,"issuer_url":"/issuer/0001402328","owner_cik":"0001474684","owner_name":"Slilaty Steve N.","owner_display_name":"Slilaty Steve N.","owner_url":"/insider/0001474684","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":253082.0,"shares_display":"253,082","price_per_share":0.1976,"price_display":"0.20","price_state":"stated","total_value":50009.0032,"total_display":"50,009.00","total_whole":"50,009","shares_owned_after":30570776.0,"shares_owned_after_display":"30,570,776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-12","filed_date":"2016-04-26","scope":"insider"},{"id":8629314,"accession":"0001013596-15-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013596-15-000003","line_url":"/filing/0001013596-15-000003#line-1","is_derivative":false,"issuer_cik":"0001402328","issuer_name":"Sunshine Biopharma, Inc","issuer_ticker":"SBFM","issuer_name_source":null,"issuer_url":"/issuer/0001402328","owner_cik":"0001474684","owner_name":"Slilaty Steve N.","owner_display_name":"Slilaty Steve N.","owner_url":"/insider/0001474684","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Series \"B\" Preferred Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":500000.0,"shares_owned_after_display":"500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2015-06-01","scope":"insider"},{"id":2182871,"accession":"0001013596-12-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013596-12-000006","line_url":"/filing/0001013596-12-000006#line-2","is_derivative":false,"issuer_cik":"0001402328","issuer_name":"Sunshine Biopharma, Inc","issuer_ticker":"SBFM","issuer_name_source":null,"issuer_url":"/issuer/0001402328","owner_cik":"0001474684","owner_name":"Slilaty Steve N.","owner_display_name":"Slilaty Steve N.","owner_url":"/insider/0001474684","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2591500.0,"shares_display":"2,591,500","price_per_share":0.05,"price_display":"0.05","price_state":"stated","total_value":129575.0,"total_display":"129,575.00","total_whole":"129,575","shares_owned_after":31517694.0,"shares_owned_after_display":"31,517,694","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-04","filed_date":"2012-09-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001402328","name":"Sunshine Biopharma, Inc","url":"/issuer/0001402328","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":5,"first_seen":"2012-09-07","last_seen":"2024-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001474684","retrieved_at":"2026-08-24T19:12:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}